Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Methotrexate (oral liquid)

EU orphan designation number: EU/3/07/495   
Active ingredient: Methotrexate (oral liquid)
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: Orbona Pharma Ltd
Old Chambers, 93-94 West Street, Farnham, Surrey GU97EB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/10/2007 Orphan designation EMEA/OD/064/07 (2007)5297 of 24/10/2007
19/05/2014 Transfer of orphan designation EMA/OD/064/07/T/01 (2014)3381 of 15/05/2014
04/10/2014 Change of name and/or address of sponsor